Skip to content
Amplicore Inc. logo — At Amplicore, we develop injectable therapeutics to serve un...

Amplicore Inc.

At Amplicore, we develop injectable therapeutics to serve unmet medical needs in musculoskeletal disorders.

Founded 2019 United States Indianapolis, United States 7 employees Seed Total: $4.00M Biotechnology, Health Care +1

General Information

Company Name Amplicore Inc.
Founded Year 2019
Location United States Indianapolis, United States
Founders / Decision Makers
Team member Team member
Employees 7
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Business Model B2B, B2C, B2D
Revenue Model Product Sales, Licensing, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Amplicore Inc.. To contact Amplicore Inc., visit amplicorepharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amplicore Inc. compare?

A PDF of Amplicore Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amplicore Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amplicore Inc.

Amplicore Inc., founded in 2019, is a pioneering biotechnology company based in the United States. The company operates in the Biotechnology, Health Care, and Health and Wellness sectors. Its mission, encapsulated in the slogan, "At Amplicore, we develop injectable therapeutics to serve unmet medical needs in musculoskeletal disorders," underscores its commitment to innovative, minimally invasive solutions for degenerative musculoskeletal disorders.

Amplicore differentiates itself by focusing on regenerative approaches to conditions such as joint osteoarthritis and degenerative disc disease, not only alleviating pain but also targeting the root causes of joint discomfort. The company's strategic vision is to convert scientific advancements into practical therapies easily accessible to patients.

The company's latest capital infusion was a $4.00M Seed Round on March 25, 2021, backed by reputable investors including ITIC: Industrial Technology Investment Corporation, Berkeley Catalyst Fund, Photon Fund, and SVE Capital, emphasizing industry confidence in its visionary approach.

Business keywords: Injectable therapeutics, Musculoskeletal disorders, Regenerative medicine, Osteoarthritis, Cartilage damage, Degenerative disc disease, Meniscus tear, Medical innovation, Minimally invasive, Joint discomfort, Pain relief, Drug development, Medical technology, Healthcare innovation

Services & Products

Development of Regenerative Injectable Therapeutics
Research and Development in Osteoarthritis and Musculoskeletal Disorders
Innovative Scientific Solutions for Joint Health

Target Customers

Patients with Osteoarthritis Individuals with Joint Discomfort Healthcare Providers Specializing in Musculoskeletal Disorders Clinics and Hospitals Offering Regenerative Medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $4.00M 4
ITIC: Industrial Technology Investment Corporation, Berkeley Catalyst Fund +2
25 Mar 2021

Amplicore Inc. Alternatives & Competitors

View All Alternatives
Amplicore Inc. vs

Developing a disease-modifying regenerative therapy for degenerative disc disease

5 employees
Biotechnology, Health Care
Amplicore Inc. vs

The Next Generation in Urology Therapeutics

Venture round
10 employees
Health Care, Health and Wellness
Amplicore Inc. vs
Disc Dynamics
Disc Dynamics United States

Based in Eden Prairie, Minnesota, Disc Dynamics, Inc. (DDI) is an orthopedic spine company founded t...

Series F
7 employees
Health Care, Health and Wellness

FAQ About Amplicore Inc.

At Amplicore, we develop injectable therapeutics to serve unmet medical needs in musculoskeletal disorders.
Amplicore Inc. was founded in 2019.
Amplicore Inc. is headquartered in Indianapolis, United States.
Amplicore Inc. operates in Biotechnology, Health Care and Health and Wellness. Its work centres on Injectable therapeutics, Musculoskeletal disorders, Regenerative medicine and Osteoarthritis. Its customers include Patients with Osteoarthritis, Individuals with Joint Discomfort and Healthcare Providers Specializing in Musculoskeletal Disorders.
Amplicore Inc. has a B2B, B2C and B2D business model. Its revenue comes from Product Sales, Licensing and Service Fee.
Amplicore Inc. has approximately 7 employees.
Amplicore Inc. has completed 1 funding round, raising a total of $4.00M. The latest funding stage is Seed.
Amplicore Inc. offers: Development of Regenerative Injectable Therapeutics, Research and Development in Osteoarthritis and Musculoskeletal Disorders, Innovative Scientific Solutions for Joint Health.
Top alternatives and competitors to Amplicore Inc. include Notogen Inc., Vensica Medical, Disc Dynamics, OBTG, Michigan Sports and Spine Center. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amplicore Inc. and Notogen Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amplicore Inc., https://bouncewatch.com/company/amplicore, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout